ABEO Stock Analysis: Buy, Sell, or Hold?
ABEO - Abeona Therapeutics Inc. Common Stock
$5.44
-0.08 (-1.45%)
▼
5d:
-0.91%
30d:
-1.45%
90d:
+5.02%
BUY
HIGH Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When ABEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ABEO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ABEO trading at deep discount. Market pricing in -4.4% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ABEO trading at deep discount. Market pricing in -4.4% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.72
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABEO is currently trading at $5.44, which is considered oversold relative to its 30-day fair value range of $5.24 to $5.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 19.0) compared to its historical average (21.7). Remarkably, the market is currently pricing in an annual earnings decline of 4.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ABEO is in a uptrend. Immediate support is located at $5.08, while resistance sits at $6.01.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.71 (+262.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABEO is in a uptrend. Immediate support is located at $5.08, while resistance sits at $6.01.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.71 (+262.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.24 -
$5.77
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 262.4% below Wall St target ($19.71)
Trading Range Analysis
30-Day Trading Range
$5.24 -
$5.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.08
Resistance Level
$6.02
Current Trend
Uptrend
Technical data as of
May 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.97
Wall Street Target
$19.71
(+262.4%)
Revenue Growth (YoY)
-100.0%
Profit Margin
454.9%
Valuation Discount vs History
-4.4% cheaper
PE vs Historical
19.0 vs 21.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.4%
(market-implied from PE analysis)
1-Year Target
$5.20
(-4%)
2-Year Target
$4.97
(-9%)
3-Year Target
$4.75
(-13%)
3-Yr Target (if PE normalizes)
(PE: 19→22)
$5.44
(0%)
📈
Valuation based on Current Earnings
Trailing PE: 5.88 | Current EPS (TTM): $0.95
Bull Case
$3.07
(-44%)
Analyst growth -50.0%, PE expands to 6.5
Base Case
$2.79
(-49%)
Market implied -50.0%, PE stable at 5.9
Bear Case
$3.80
(-30%)
Severe decline -20.0%, PE contracts to 5.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.0 to 21.7
Stabilization Target:
$6.22
(+14.4%)
PE Expansion Potential:
+14.4%
Share & Embed Analysis
Last updated: May 25, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Crombez
SELL
16284 shares
2026-02-02
Leila Alland
SELL
18065 shares
2026-02-02
Mark Alvino
SELL
2000 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 60 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 63 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 54 HOLD |
